statistiche ricercatore

CAMPIOTTI, LEONARDO

Distribuzione geografica

Continente	#
NA - Nord America	4.975
EU - Europa	2.834
AS - Asia	466
SA - Sud America	6
Continente sconosciuto - Info sul continente non disponibili	4
OC - Oceania	3
AF - Africa	1
Totale	8.289

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	4.970
IT - Italia	1.627
UA - Ucraina	397
SE - Svezia	285
VN - Vietnam	178
DE - Germania	169
IE - Irlanda	139
TR - Turchia	127
CN - Cina	125
FR - Francia	74
GB - Regno Unito	50
FI - Finlandia	42
BE - Belgio	12
IN - India	12
JP - Giappone	8
CA - Canada	5
PT - Portogallo	5
RU - Federazione Russa	5
BR - Brasile	4
EU - Europa	4
AU - Australia	3
CH - Svizzera	3
ES - Italia	3
MD - Moldavia	3
MK - Macedonia	3
PL - Polonia	3
BD - Bangladesh	2
KZ - Kazakistan	2
MY - Malesia	2
NL - Olanda	2
PH - Filippine	2
RO - Romania	2
RS - Serbia	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
BG - Bulgaria	1
CL - Cile	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
EG - Egitto	1
GR - Grecia	1
HK - Hong Kong	1
HU - Ungheria	1
LK - Sri Lanka	1
LT - Lituania	1
LU - Lussemburgo	1
MN - Mongolia	1
NO - Norvegia	1
NP - Nepal	1
PE - Perù	1
SA - Arabia Saudita	1
SG - Singapore	1
Totale	8.289

Salva come PNG Salva come JPEG

Città	#
Milan	1.032
Fairfield	816
Chandler	439
Woodbridge	414
Ashburn	391
Houston	335
Seattle	323
Jacksonville	319
Wilmington	319
Cambridge	260
Ann Arbor	210
Dearborn	180
Nyköping	178
Princeton	156
Dublin	139
Como	109
Dong Ket	85
Rome	77
New York	64
Izmir	59
San Diego	59
Kocaeli	44
Beijing	38
Redmond	37
Ogden	31
San Mateo	25
Kunming	14
Hefei	12
Redwood City	12
Boardman	11
Brussels	11
Frankfurt am Main	11
Norwalk	11
Helsinki	10
Nanjing	10
Washington	10
Los Angeles	8
London	7
Tokyo	7
Berlin	6
Nanchang	6
Pune	6
Verona	6
Chiswick	5
Falls Church	5
Jinan	5
Antibes	4
Bollate	4
Genoa	4
Guangzhou	4
Legnano	4
Missaglia	4
Mountain View	4
Napoli	4
San Severo	4
São Paulo	4
Toronto	4
Trieste	4
Acton	3
Arezzo	3
Auburn Hills	3
Cervere	3
Cincinnati	3
Düsseldorf	3
Hebei	3
Indiana	3
Kilburn	3
Parma	3
Ponte Lambro	3
San Francisco	3
San Giorgio Su Legnano	3
Skopje	3
Turin	3
Varese	3
Almaty	2
Athis-mons	2
Bologna	2
Bregnano	2
Brescia	2
Carignano	2
Carpineti	2
Casorate Primo	2
Castiglione delle Stiviere	2
Changsha	2
Chengdu	2
Chicago	2
Chisinau	2
Chongqing	2
Dallas	2
Dasmarinas	2
Deiva Marina	2
Dhaka	2
Dronero	2
Esslingen am Neckar	2
Florence	2
Fuzhou	2
Hangzhou	2
Hanoi	2
Istanbul	2
Kuala Lumpur	2
Totale	6.460

Salva come PNG Salva come JPEG

Nome	#
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment	195
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis	192
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both	191
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells	179
Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis	176
Fatal Splenic Rupture in a Previously Undiagnosed Multiple Myeloma: Morphological, Immunophenotypical and Molecular Cytogenetic Analyses	164
Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)	162
Right ventricular remodelling in mild hypertensive patients: role of left ventricular morpho-functional parameters	160
JAK2-V617F mutation and Philadelphia positive chronic myeloid leukemia.	154
sRAGE and early signs of cardiac target organ damage in mild hypertensives	152
JAK2, 46/1 haplotype and chronic myelogenous leukemia: diagnostic and therapeutic potential	150
In vitro effects of Apixaban on 5 different cancer cell lines	149
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations—comment	149
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia	146
Clinical Impact of an Accurate Genetic Characterization of Older Acute Myeloid Leukemia Patients: A Report from the Northern Italy Leukemia Group (NILG) Randomized Trial 02/06	146
Imatinib (IM) discontinuation in chronic myeloid leukemia (CML): A pharmacogenetic score for patients with durable complete molecular response (CMR)	144
Tirosine kinase inhibitors adverse events	143
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML	142
Bone marrow necrosis related to imatinib mesylate therapy for cml bilineal blast crisis	141
Primary extranodal diffuse large B-cell lymphomas: Many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases	141
A particular case of AML patient with the polymorphism G105G (rs11554137) and the missense mutation R132C in IDH1 gene	138
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.	138
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register	135
Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia	134
Acute myeloid leukemia with associated translocation t(15;17) and 11q23/MLL abnormality	134
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients	134
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia	131
JAK2 mutation and atypical chronic myeloid leukemia	130
Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia	130
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub	129
Assessing residual disease in imatinib-treated CML patients by DNA compared to MRNA assays	127
A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study).	124
Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia	122
Metabolic tumour volume and response to therapy in diffuse large B cell lymphoma	118
Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia	116
Prevention of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis	111
Molecular monitoring of residual disease in chronic myeloid leukemia by genomic DNA compared with conventional mRNA analysis.	104
Caspofungin Primary Antifungal Prophylaxis in Acute Leukemia Patients During Induction Therapy: Results of a Prospective Phase II Multicentric Study (ProfilC Study)	100
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards	99
Baseline PET as prognostic index in diffuse large B-cell lymphoma and grade IIIb follicular lymphoma: a retrospective study of a single-centre experience	98
Comment on low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study	97
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study	96
Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06	93
IN ADULT ACUTE MYELOID LEUKAEMIA (AML) ALL RISK SUBSETS BENEFIT FROM A SEQUENTIAL HIGH-DOSE PROGRAMME AS EARLY RESCUE OF FIRST INDUCTION FAILURE: A REPORT FROM NORTHERN ITALY LEUKAEMIA GROUP (NILG)	85
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia	85
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people	85
Tyrosin-Kinase Inhibitors Discontinuation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis	84
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients	84
Negative impact of high body mass index on cetuximab-mediated cellular cytotoxicity against human colon carcinoma cells	82
Clinical features, treatment and outcome of patients with low-grade gastric MALT lymphoma: a single centre experience	82
CEOP 1-8 regimen for treatment of intermediate-high grade non-Hodgkin's lymphoma in elderly patients	79
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry	79
What changed in the Italian internal medicine and geriatric wards during the lockdown	78
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry	76
Subacute demyelinating polyneuropathy associated with B-cell lymphoma and IgM antibodies against myelin-associated glycoprotein responsive to rituximab	75
Primary testicular non-Hodgkin lymphomas. A clinicopathologic study of nine cases	75
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients	74
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register	72
Pain and Frailty in Hospitalized Older Adults	71
MOLECULAR PROLIFE BY NEXT GENERATION SEQUENCING OF ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE: CLINICAL RESULTS FROM THE PROSPECTIVE TRIAL 02/06 OF THE NORTHERN ITALY LEUKEMIA GROUP (NILG)	71
CLINICAL SIGNIFICANCE OF END OF INDUCTION MINIMAL RESIDUAL DISEASE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION AFTER A SINGLE CHEMOTHERAPY COURSE	71
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry	71
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)	70
TWO-STEP RESPONSE-ORIENTED INDUCTION PREDICTS LONG-TERM OUTCOME OF ADULT PATIENTS WITH STANDARD- AND HIGH-RISK ACUTE MYELOID LEUKAEMIA (AML): A NORTHERN ITALY LEUKAEMIA GROUP (NILG) STUDY	69
Primary gastric lymphomas. Clinico-pathological study and evaluation of prognostic factors in 65 cases treated surgically	68
NEXT GENERATION SEQUENCING (NGS) CONFIRMED THE ADVERSE CLINICAL IMPACT OF RUNX1 MUTATIONS IN A SUBSET OF ACUTE MYELOID LEUKEMIA NORMAL KARYOTYPE PATIENTS NEGATIVE FOR RISK DEFINING GENES MUTATIONS AND HOMOGENOUSLY TREATED WITHIN A CLINICAL TRIAL (NILG AML 02/06)	66
Evaluation of international prognostic factors project for patients with advanced Hodgkin's disease: A single centre experience	65
Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study	65
Composite follicular lymphoma and “early” (in situ and mantle zone growth pattern) mantle cell neoplasia: A rare entity with peculiar cytogenetic and clinical features	62
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06	60
Antibiotic use and associated factors in a large sample of hospitalised older people	59
Post-Treatment Residual Disease Detection by Droplet Digital PCR in Hairy Cell Leukemia: Comparison with Allele Specific PCR and Immunohistochemistry	55
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients	54
Association of ARA-C, mitoxantrone and etoposide in elderly affected by acute myeloid leucemia	51
PROGNOSTIC VALUE OF CLONAL HEMATOPOIESIS-MUTATIONS DETECTED AT DIAGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE	51
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register)	47
Low efficacy of thalidomide in improving response after induction in myeloma patients candidate to high-dose therapy	32
Association of hairy cell leucemia (HCL) with low-grade non Hodgkin lymphoma (NHL) successfully treated with retuximab. A case report	32
Primary non-Hodgkin's lymphoma of the kidney: A case report	30
Integrated genomic, functional, and prognostic characterization of atypical chronic myeloid leukemia	30
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients	17
BCL2 in follicular lymphomas (FL): the overrated guy?	12
Body mass index (BMI) influence on Cetuximab-induced antibody-dependent cellular cytotoxicity in advanced colon cancer	11
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register	11
A case of multicentric Castleman's disease mimicking non-Hodgkin lymphoma: when splenectomy is diagnostic and therapeutic	8
Correction to: Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register	7
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study	5
High frequency of BCL2 gene rearrangement-negative follicular lymphoma in northwestern Italy	5
Correction to: Direct oral anticoagulants in patients with a left-sided bioprosthetic heart valve: a systematic review and meta‑analysis (Internal and Emergency Medicine, (2023), 18, 2, (535-547), 10.1007/s11739-023-03208-9)	4
Direct oral anticoagulants in patients with a left-sided bioprosthetic heart valve: a systematic review and meta-analysis	1
Totale	8.440

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	32.629
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	32.629

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	165	0	0	0	0	0	0	0	0	0	0	0	165
2019/2020	1.747	57	51	101	299	125	203	271	224	161	102	39	114
2020/2021	2.076	48	149	155	182	213	213	148	152	212	233	167	204
2021/2022	915	134	98	40	55	35	106	33	30	53	171	64	96
2022/2023	1.253	130	86	90	128	101	234	1	189	186	37	36	35
2023/2024	1.724	263	260	244	319	303	159	16	27	62	30	17	24
Totale													8.440